Since FeSO4 strongly activates GR in the liver (Figure 1), we investigated whether DEX is able to protect against a lethal dose of FeSO4 (300 mg/kg) using the same experimental set-up as in LPS-induced endotoxemia. The gene discussed is NR3C1; the disease is serum lipopolysaccharide activity.